Patents by Inventor Hossein Pajouhesh

Hossein Pajouhesh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Preferentially substituted calcium channel blockers
    Patent number: 7186726
    Abstract: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
    Type: Grant
    Filed: September 3, 2003
    Date of Patent: March 6, 2007
    Assignee: Neuromed Pharmaceuticals Ltd.
    Inventors: Terrance P. Snutch, Gerald W. Zamponi, Hassan Pajouhesh, Hossein Pajouhesh, Francesco Belardetti
  • Diamine calcium channel blockers
    Publication number: 20060235050
    Abstract: Aromatic derivatives of aliphatic diamines are effective in ameliorating conditions characterized by unwanted calcium ion channel activity, especially T-type and N-type channels. These conditions include, for example, stroke and pain.
    Type: Application
    Filed: February 8, 2006
    Publication date: October 19, 2006
    Applicant: Nueromed Technologies, Inc.
    Inventors: Hassan Pajouhesh, Hossein Pajouhesh, Yanbing Ding, Terrance Snutch, Francesco Belardetti
  • Calcium channel blockers comprising two benzhydril moieties
    Publication number: 20060084660
    Abstract: Certain piperazine compounds are described which are useful in altering calcium channel activity.
    Type: Application
    Filed: August 29, 2005
    Publication date: April 20, 2006
    Inventors: Terrance Snutch, Gerald Zamponi, Hassan Pajouhesh, Hossein Pajouhesh, Francesco Belardetti
  • Urea derivatives as calcium channel blockers
    Publication number: 20060063775
    Abstract: Urea derivatives which comprise piperidine or piperazine rings and further substitution are effective in ameliorating conditions characterized by unwanted calcium ion channel activity.
    Type: Application
    Filed: August 30, 2005
    Publication date: March 23, 2006
    Inventors: Hassan Pajouhesh, Hossein Pajouhesh, Yanbing Ding, Terrance Snutch
  • Diarylamine derivatives as calcium channel blockers
    Publication number: 20050227999
    Abstract: Compounds which are derivatives of diarylamine substituted piperazine and amino-piperidine are useful in treating conditions mediated by calcium ion channel activity.
    Type: Application
    Filed: August 27, 2004
    Publication date: October 13, 2005
    Inventors: Hassan Pajouhesh, Hossein Pajouhesh, Yanbing Ding, Terrance Snutch
  • Calcium channel blockers comprising two benzhydril moieties
    Patent number: 6951862
    Abstract: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
    Type: Grant
    Filed: April 8, 2003
    Date of Patent: October 4, 2005
    Assignee: Neuromed Technologies, Inc.
    Inventors: Terrance P. Snutch, Gerald W. Zamponi, Hassan Pajouhesh, Hossein Pajouhesh, Francesco Belardetti
  • Calcium channel blockers comprising two benzhydril moieties
    Patent number: 6949554
    Abstract: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
    Type: Grant
    Filed: December 23, 2003
    Date of Patent: September 27, 2005
    Assignee: NeuroMed Technologies Inc.
    Inventors: Terrance P. Snutch, Gerald W. Zamponi, Hassan Pajouhesh, Hossein Pajouhesh, Francesco Belardetti
  • Calcium channel inhibitors comprising benzhydril spaced from piperazine
    Patent number: 6943168
    Abstract: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
    Type: Grant
    Filed: April 8, 2003
    Date of Patent: September 13, 2005
    Assignee: NeuroMED Technologies Inc.
    Inventors: Terrance P. Snutch, Gerald W. Zamponi, Hassan Pajouhesh, Hossein Pajouhesh, Francesco Belardetti
  • N-type calcium channel blockers
    Publication number: 20050165065
    Abstract: The invention relates to novel 3-amino pyrrolidine derivatives, as well as methods for modulating calcium channel activity and for treating conditions associated with calcium channel function. In particular, the compounds generally contain at least one benzhydril moiety, and are useful in treating conditions which benefit from blocking calcium ion channels.
    Type: Application
    Filed: January 22, 2004
    Publication date: July 28, 2005
    Inventors: Hassan Pajouhesh, Hossein Pajouhesh, Yanbing Ding, Terrance Snutch
  • N-type calcium channel blockers
    Publication number: 20050014748
    Abstract: Compounds that are derivatives of 3-aminomethyl-pyrrolidine generally containing at least one benzhydril moiety are useful in treating conditions which benefit from blocking calcium ion channels.
    Type: Application
    Filed: May 28, 2004
    Publication date: January 20, 2005
    Inventors: Hassan Pajouhesh, Terrance Snutch, Hossein Pajouhesh, Yanbing Ding
  • Calcium channel inhibitors comprising benzhydril spaced from piperazine
    Publication number: 20040266784
    Abstract: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
    Type: Application
    Filed: April 9, 2004
    Publication date: December 30, 2004
    Inventors: Terrance P. Snutch, Gerald W. Zamponi, Hassan Pajouhesh, Francesco Belardetti, Hossein Pajouhesh
  • Calcium channel blockers comprising two benzhydril moieties
    Publication number: 20040259866
    Abstract: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
    Type: Application
    Filed: April 9, 2004
    Publication date: December 23, 2004
    Inventors: Terrance P. Snutch, Gerald W. Zamponi, Hassan Pajouhesh, Francesco Belardetti, Hossein Pajouhesh
  • Calcium channel blockers comprising two benzhydril moieties
    Publication number: 20040209872
    Abstract: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
    Type: Application
    Filed: December 23, 2003
    Publication date: October 21, 2004
    Inventors: Terrance P. Snutch, Gerald W. Zamponi, Hassan Pajouhesh, Hossein Pajouhesh, Francesco Belardetti
  • Preferentially substituted calcium channel blockers
    Publication number: 20040147529
    Abstract: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
    Type: Application
    Filed: September 3, 2003
    Publication date: July 29, 2004
    Inventors: Terrance P. Snutch, Gerald W. Zamponi, Hassan Pajouhesh, Hossein Pajouhesh, Francesco Belardetti
  • Calcium channel inhibitors comprising benzhydril spaced from piperazine
    Publication number: 20040044004
    Abstract: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
    Type: Application
    Filed: April 8, 2003
    Publication date: March 4, 2004
    Applicant: NeuroMed Technologies, Inc.
    Inventors: Terrance P. Snutch, Gerald W. Zamponi, Hassan Pajouhesh, Hossein Pajouhesh, Francesco Belardetti
  • Calcium channel inhibitors comprising benzhydril spaced from piperazine
    Publication number: 20040034035
    Abstract: Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
    Type: Application
    Filed: April 8, 2003
    Publication date: February 19, 2004
    Applicant: NeuroMed technologies, Inc.
    Inventors: Terrance P. Snutch, Gerald W. Zamponi, Hassan Pajouhesh, Hossein Pajouhesh, Francesco Belardetti